trending Market Intelligence /marketintelligence/en/news-insights/trending/eukhjf64qqv4vb-pxssucg2 content esgSubNav
In This List

Orthofix gets US FDA approval for foot bone implant

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Orthofix gets US FDA approval for foot bone implant

Orthofix International NV said the U.S. Food and Drug Administration granted 510(k) clearance to its G-Beam fusion beaming system to treat Charcot foot, a condition where the bones in the foot weaken and collapse.

The Lewisville, Texas-based device-maker said the G-Beam devices can be implanted in the medial and lateral columns of the foot to provide alignment, stabilization and fixation.